The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Identification of galectin-3 as an autoantigen in patients with IgG4-related disease
Open accessAbstract
Background: The antigenic trigger that drives expansion of circulating plasmablasts and CD4+ cytotoxic T cells in patients with IgG4‐related disease (IgG4‐RD) is presently unknown. Objective: We sought to sequence immunoglobulin genes from single‐cell clones of dominantly expanded plasmablasts and generate recombinant human mAbs to identify relevant antigens in patients with IgG4‐RD by using mass spectrometry. Methods: Paired heavy and light chain cDNAs from dominant plasmablast clones were expressed as mAbs and used to purify antigens by using immunoaffinity chromatography. Affinity‐purified antigens were identified by using mass spectrometry and validated by means of ELISA. Plasma levels of the antigen of interest were also determined by using ELISA. Results: mAbs expressed from the 2 dominant plasmablast clones of a patient with multiorgan IgG4‐RD stained human pancreatic tissue sections. Galectin‐3 was identified as the antigen specifically recognized by both mAbs. Anti–galectin‐3 autoantibody responses were predominantly of the IgG4 isotype (28% of the IgG4‐RD cohort, P = .0001) and IgE isotype (11% of the IgG4‐RD cohort, P = .009). No significant responses were seen from the IgG1, IgG2, or IgG3 isotypes. IgG4 anti–galectin‐3 autoantibodies correlated with increased plasma galectin‐3 levels (P = .001), lymphadenopathy (P = .04), total IgG level increase (P = .05), and IgG4 level increase (P = .03). Conclusion: Affinity chromatography using patient‐derived mAbs identifies relevant autoantigens in patients with IgG4‐RD. IgG4 galectin‐3 autoantibodies are present in a subset of patients with IgG4‐RD and correlate with galectin‐3 plasma levels. The marked increases in levels of circulating IgG4 and IgE observed clinically are, at least in part, caused by the development of IgG4‐ and IgE‐specific autoantibody responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics
Ting, L., Rad, R., Gygi, S. P., & Haas, W. (2011) · Nature Methods · doi:10.1038/nmeth.1714 · Cited by 1,009 · cited 1×
“Generated peptides from the individual samples were derivatized with 10-plex tandem mass tag reagents (Thermo Fisher), and protein concentration differences between the samples were determined by using multiplexed quantitative proteomics with synchronous-precursor-selection MS3 technology on an Orbitrap Fusion Mass Sp…”
Self-citationGalectin-3 Expression and Secretion Links Macrophages to the Promotion of Renal Fibrosis
Henderson, N. C., Mackinnon, A. C., Farnworth, S. L., Kipari, T., Haslett, C., Iredale, J. P., Liu, F.-T., Hughes, J., & Sethi, T. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070726 · Cited by 562
Cited by
IgG4-related disease: an update on pathophysiology and implications for clinical care
Perugino, C. A., & Stone, J. H. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0500-7 · Cited by 421
Self-citationAdvances in the diagnosis and management of IgG4 related disease
Lanzillotta, M., Mancuso, G., & Della-Torre, E. (2020) · BMJ · doi:10.1136/bmj.m1067 · Cited by 360
Self-citationThe Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases
Cargill, T., & Culver, E. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.661196 · Cited by 46
Metadata
- Authors
- Perugino, C. A., AlSalem, S. B., Mattoo, H., Della-Torre, E., Mahajan, V., Ganesh, G., Allard-Chamard, H., Wallace, Z., Montesi, S. B., Kreuzer, J., Haas, W., Stone, J. H., & Pillai, S.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 143
- Issue
- 2
- Pages
- 736-745.e6
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W2807281772
- Cited by
- 176
- References
- 2
- FWCI
- 14.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Identification of galectin-3 as an autoantigen in patients with IgG4-related disease. https://app.cochat.ai/papers/10.1016/j.jaci.2018.05.011
- The paper
- Perugino, C. A., AlSalem, S. B., Mattoo, H., Della-Torre, E., Mahajan, V., Ganesh, G., Allard-Chamard, H., Wallace, Z., Montesi, S. B., Kreuzer, J., Haas, W., Stone, J. H., & Pillai, S. (2019). Identification of galectin-3 as an autoantigen in patients with IgG4-related disease. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2018.05.011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.